HIV, metabolic syndrome X, inflammation, oxidative stress, and coronary heart disease risk : role of protease inhibitor exposure.
Hurwitz BE, Klimas NG, Llabre MM, Maher KJ, Skyler JS, Bilsker MS, McPherson-Baker S, Lawrence PJ, Laperriere AR, Greeson JM, Klaus JR, Lawrence R, Schneiderman N.
Hurwitz BE, et al. Among authors: schneiderman n.
Cardiovasc Toxicol. 2004;4(3):303-16. doi: 10.1385/ct:4:3:303.
Cardiovasc Toxicol. 2004.
PMID: 15470277
Clinical Trial.